NDC codes

415464 NDC codes with hospital pricing data in the network.

• NDC 47781-0616-17 — Rocuronium injection for muscle relaxation (10 mg/mL)AI (115 hospitals, 29,399–30,398 samples)
• NDC 43598-0210-25 — Silver sulfadiazine 1% topical creamAI (511 hospitals, 29,425–30,388 samples)
• NDC 00168-0004-16 — TRIAMCINOLONE ACETONIDE 0.1 % TOPICAL CREAMAI (208 hospitals, 29,402–30,383 samples)
• NDC 00713-0640-15 — HALOBETASOL PROPIONATE 0.05 % TOPICAL CREAMAI (86 hospitals, 29,402–30,383 samples)
• NDC 71266-5010-01 — Fentanyl injection in saline, intravenousAI (121 hospitals, 28,767–30,378 samples)
• NDC 47781-0426-11 — Fentanyl 72-hour skin patch, 50 mcg per hourAI (373 hospitals, 29,413–30,376 samples)
• NDC 00409-1171-01 — Diltiazem 5 mg/mL intravenous injection solutionAI (145 hospitals, 29,809–30,376 samples)
• NDC 45802-0139-70 — Metronidazole 0.75% vaginal gelAI (416 hospitals, 29,427–30,372 samples)
• NDC 00121-0868-50 — Nystatin 100,000 unit/mL oral suspensionAI (246 hospitals, 29,745–30,366 samples)
• NDC 45802-0129-35 — HALOBETASOL PROPIONATE 0.05 % TOPICAL CREAMAI (107 hospitals, 29,393–30,365 samples)
• NDC 00168-0005-80 — TRIAMCINOLONE ACETONIDE 0.025 % TOPICAL OINTMENTAI (123 hospitals, 29,464–30,364 samples)
• NDC 51754-0103-04 — Cupric chloride intravenous solutionAI (216 hospitals, 29,430–30,348 samples)
• NDC 00409-4888-10 — Preservative-free sodium chloride 0.9% injectionAI (649 hospitals, 28,968–30,345 samples)
• NDC 17478-0705-10 — Betaxolol eye drops 0.5%AI (141 hospitals, 29,534–30,344 samples)
• NDC 65219-0401-00 — Zinc sulfate intravenous solutionAI (54 hospitals, 29,534–30,344 samples)
• NDC 59762-0131-05 — SILVER SULFADIAZINE 1 % TOPICAL CREAMAI (129 hospitals, 29,379–30,342 samples)
• NDC 00591-2258-54 — Scopolamine 1 mg transdermal patch (3-day)AI (127 hospitals, 29,397–30,333 samples)
• NDC 16714-0527-01 — Ipratropium bromide nasal sprayAI (234 hospitals, 29,397–30,333 samples)
• NDC 71921-0226-10 — Dorzolamide-timolol eye drops, 2% and 0.5%AI (238 hospitals, 29,397–30,333 samples)
• NDC 00168-0301-15 — Clobetasol topical cream 0.05%AI (84 hospitals, 29,397–30,333 samples)
• NDC 00574-4012-10 — Brinzolamide 1% eye dropsAI (72 hospitals, 29,523–30,333 samples)
• NDC 51672-1386-02 — Fluocinonide 0.05% cream, 30 g tubeAI (214 hospitals, 29,397–30,333 samples)
• NDC 45802-0063-05 — TRIAMCINOLONE ACETONIDE 0.025 % TOPICAL CREAMAI (53 hospitals, 29,397–30,333 samples)
• NDC 60505-0578-04 — Azelastine 0.05% eye drops, 6 mL bottleAI (237 hospitals, 29,378–30,332 samples)
• NDC 63323-0472-03 — Bupivacaine 0.75% preservative-free injectionAI (125 hospitals, 26,964–30,330 samples)
• NDC 00781-3220-92 — Rocuronium injection, 10 mg per mLAI (169 hospitals, 29,397–30,324 samples)
• NDC 00019-1323-02 — Ioversol 320 contrast injectionAI (93 hospitals, 29,270–30,323 samples)
• NDC 51672-1263-02 — Nystatin and triamcinolone skin creamAI (231 hospitals, 29,377–30,322 samples)
• NDC 61314-0014-05 — Diclofenac sodium 0.1% eye dropsAI (341 hospitals, 29,422–30,322 samples)
• NDC 45802-0055-36 — TRIAMCINOLONE ACETONIDE 0.1 % TOPICAL OINTMENTAI (330 hospitals, 29,377–30,322 samples)
• NDC 45802-0466-11 — ECONAZOLE NITRATE 1 % TOPICAL CREAMAI (116 hospitals, 29,422–30,322 samples)
• NDC 51672-1274-01 — BETAMETHASONE DIPROPIONATE 0.05 % TOPICAL CREAMAI (100 hospitals, 29,377–30,322 samples)
• NDC 61314-0227-10 — Timolol eye drops 0.5%AI (373 hospitals, 29,377–30,322 samples)
• NDC 66887-0001-05 — Testosterone 1% transdermal gel, 50 mg per 5 gAI (94 hospitals, 29,422–30,322 samples)
• NDC 51672-1303-02 — Econazole 1% cream, 30 g tubeAI (169 hospitals, 29,377–30,322 samples)
• NDC 58602-0007-39 — OLOPATADINE 0.2 % EYE DROPSAI (147 hospitals, 29,377–30,322 samples)
• NDC 00781-7304-58 — Rivastigmine 4.6 mg/24-hour transdermal patchAI (272 hospitals, 29,377–30,322 samples)
• NDC 51672-1284-02 — TRIAMCINOLONE ACETONIDE 0.1 % TOPICAL OINTMENTAI (129 hospitals, 29,377–30,322 samples)
• NDC 62332-0506-06 — Azelastine eye drops 0.05%AI (63 hospitals, 29,377–30,322 samples)
• NDC 63323-0032-00 — Sodium acetate 4 mEq/mL solution, 100 mL vialAI (200 hospitals, 29,551–30,316 samples)
• NDC 39328-0029-12 — Hydrocortisone 25 mg rectal suppositoryAI (96 hospitals, 29,376–30,312 samples)
• NDC 00472-0379-15 — Clotrimazole-betamethasone topical creamAI (274 hospitals, 29,376–30,312 samples)
• NDC 62135-0712-42 — Viscous lidocaine 2% oral solutionAI (350 hospitals, 29,376–30,312 samples)
• NDC 81033-0512-15 — Chlorhexidine mouthwashAI (148 hospitals, 29,376–30,312 samples)
• NDC 00121-1012-05 — LACOSAMIDE 10 MG/ML ORAL SOLUTIONAI (105 hospitals, 29,376–30,312 samples)
• NDC 00555-0066-02 — Isoniazid 100 mg tabletsAI (285 hospitals, 29,689–30,310 samples)
• NDC 63323-0164-26 — Lactated Ringer's intravenous solutionAI (53 hospitals, 29,974–30,307 samples)
• NDC 47781-0428-47 — Fentanyl 100 mcg/hr transdermal patchAI (482 hospitals, 29,415–30,306 samples)
• NDC 43598-0210-85 — SILVER SULFADIAZINE 1 % TOPICAL CREAMAI (124 hospitals, 29,375–30,302 samples)
• NDC 51672-1370-01 — Mupirocin 2% topical creamAI (242 hospitals, 29,375–30,302 samples)